StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VTVT

vTv Therapeutics Inc.

VTVT Nasdaq Pharmaceutical Preparations EDGAR ↗
$32.06
-0.33 -1.02%

Key statistics

from XBRL data in SEC filings
Market cap
Revenue (TTM)
$36.8M
Net income (TTM)
$2.25M
EPS (TTM)
P/E ratio
Dividend yield
Free cash flow
Cash
$98.1M
Total assets
$98.8M
Gross margin
52-week range
$14.00 – $44.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 29, 2026 8-K Other events May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Regulation FD disclosure Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Entered a material agreement Feb 2, 2026 8-K Amended charter or bylaws Dec 19, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure Sep 10, 2025 8-K Entered a material agreement Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Director or officer change May 19, 2025 8-K Regulation FD disclosure May 16, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Director or officer change Apr 11, 2025 8-K Regulation FD disclosure Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Mar 17, 2025 8-K Director or officer change Feb 27, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Terminated a material agreement Oct 25, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Other events Jul 26, 2024 8-K Entered a material agreement Jul 2, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Other events Mar 26, 2024 8-K Director or officer change Mar 14, 2024